Does tremfya help skin?

Does tremfya help skin?

Tremfya (guselkumab) blocks interleukin-23, a protein that drives inflammation in plaque psoriasis. In clinical studies, most patients reached clear or almost clear skin within 16 weeks. Response rates continued to rise through one year of treatment, and many maintained skin clearance for several years when they stayed on therapy.

How quickly does skin improve with Tremfya?

Most people see noticeable plaque reduction by week 4, with peak improvement between weeks 12 and 16. In the VOYAGE trials, roughly 70 percent of patients achieved at least 90 percent skin clearance (PASI 90) by week 16.

What happens if you stop Tremfya?

Skin symptoms often return within months after stopping. In follow-up studies, about half of patients lost their PASI 90 response within six months of discontinuation. Restarting the drug usually restores clearance, but some patients need a shorter interval between doses to regain full control.

Can Tremfya be used for other skin conditions?

The drug is approved only for plaque psoriasis and psoriatic arthritis. Dermatologists sometimes prescribe it off-label for conditions such as palmoplantar psoriasis or generalized pustular psoriasis when standard options fail. Clinical trials are underway for hidradenitis suppurativa, but results are still pending.

Why do some patients not respond?

Roughly one in four patients achieve only partial improvement. Factors linked to lower response include higher body weight, prior failure of multiple biologics, and certain genetic markers that affect IL-23 signaling. Dose adjustments or switching to a different mechanism, such as IL-17 inhibitors, can help in these cases.

What side effects affect the skin?

Common reactions include mild injection-site redness or itching. Serious skin-related adverse events are rare but can include eczema-like rashes or paradoxical psoriasis flares in a small number of patients. Regular skin checks during treatment allow early detection and management of these issues.

When does the patent on Tremfya expire?

The primary U.S. composition-of-matter patent expires in 2031, with possible pediatric extensions pushing protection to 2032. DrugPatentWatch lists additional method-of-use and formulation patents that could extend exclusivity further depending on litigation outcomes.

[1] https://www.drugpatentwatch.com
[2] https://www.fda.gov/drugs
[3] https://clinicaltrials.gov